imatinib mesylate has been researched along with Endocrine System Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arceci, RJ; Hijiya, N; Lee, P; Samis, J; Suttorp, M; Zimmerman, D | 1 |
| Alacacioglu, I; Bilgir, F; Bilgir, O; Karaca, B; Kebapcilar, L; Oner, P; Sarì, I | 1 |
1 review(s) available for imatinib mesylate and Endocrine System Diseases
| Article | Year |
|---|---|
Recognizing Endocrinopathies Associated With Tyrosine Kinase Inhibitor Therapy in Children With Chronic Myelogenous Leukemia.
Topics: Adrenal Glands; Aniline Compounds; Antineoplastic Agents; Bone Remodeling; Child; Dasatinib; Endocrine System; Endocrine System Diseases; Fusion Proteins, bcr-abl; Glucose Metabolism Disorders; Humans; Imatinib Mesylate; Imidazoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Nitriles; Protein Kinase Inhibitors; Pyridazines; Pyrimidines; Quinolines; Thyroid Gland | 2016 |
1 other study(ies) available for imatinib mesylate and Endocrine System Diseases
| Article | Year |
|---|---|
Is there any relationship between imatinib mesylate medication and hypothalamic-pituitary-adrenal axis dysfunction?
Topics: Adrenocorticotropic Hormone; Adult; Aged; Antineoplastic Agents; Benzamides; Cosyntropin; Endocrine System Diseases; Female; Glucagon; Glucocorticoids; Hormones; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Pituitary-Adrenal System; Protein Kinase Inhibitors; Pyrimidines | 2010 |